Evidence map›Paper›PMID 30382181›Full record

ReviewActa pharmacologica Sinica2018

Drug addiction: a curable mental disorder?

Jian-Feng Liu, Jun-Xu Li

Open access · bronzeAbstract readReview
In one paragraph

Review in Acta pharmacologica Sinica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. The mechanism of the JNK signaling pathway in drug addiction : Author list.Journal of molecular medicine (Berlin, Germany) · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. GABAMedComm · 2025
    Review
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jian-Feng LiuDepartment of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, 14203, USA. jliu66@buffalo.edu.
Jun-Xu LiDepartment of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, 14203, USA. junxuli@buffalo.edu.
University at Buffalo, State University of New York · US

Funding

TAAR 1 modulation of addiction-related effects of nicotineR21DA040777 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LI, JUN-XU · 2016 to 2017
$479k
NIDA NIH HHS R21 DA040777
6 · The paper itself

Abstract

Drug addiction is a chronic, relapsing brain disorder. Multiple neural networks in the brain including the reward system (e.g., the mesocorticolimbic system), the anti-reward/stress system (e.g., the extended amygdala), and the central immune system, are involved in the development of drug addiction and relapse after withdrawal from drugs of abuse. Preclinical and clinical studies have demonstrated that it is promising to control drug addiction by pharmacologically targeting the addiction-related systems in the brain. Here we review the pharmacological targets within the dopamine system, glutamate system, trace amine system, anti-reward system, and central immune system, which are of clinical interests. Furthermore, we discuss other potential therapies, e.g., brain stimulation, behavioral treatments, and therapeutic gene modulation, which could be effective to treat drug addiction. We conclude that, although drug addiction is a complex disorder that involves complicated neural mechanisms and psychological processes, this mental disorder is treatable and may be curable by therapies such as gene modulation in the future.

Indexed as

AnimalsBehavior TherapyBrainDopamine AntagonistsElectric Stimulation TherapyExcitatory Amino Acid AntagonistsGenetic TherapyHumansReceptors, G-Protein-CoupledSubstance-Related DisordersDopamine AntagonistsExcitatory Amino Acid AntagonistsReceptors, G-Protein-Coupledbehavioral treatmentbrain stimulationdrug addictiongene therapypharmacological targets

Identifiers

PMID30382181
PMCPMC6289334
OpenAlexW2899293777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.